| Dr Tiffany Courtney Pankow, MD | |
|
4400 N 32nd St, Suite 110, Phoenix, AZ 85018-3953 | |
| (602) 956-9595 | |
| (602) 956-3232 |
| Full Name | Dr Tiffany Courtney Pankow |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 4400 N 32nd St, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164468633 | NPI | - | NPPES |
| 0409210 | Other | AZ | BCBS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 31622 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scottsdale Osborn Medical Center | Scottsdale, AZ | Hospital |
| Honorhealth Scottsdale Shea Medical Center | Scottsdale, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Honorhealth Medical Group, Llc | 1557274057 | 224 |
News Archive
In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Results from a nationwide study in the USA show that women of menopausal age have a rate of asthma hospitalization that is more than twice that of men of the same age.
A clinical trial studying the body's ability to fight type 1 diabetes using cell therapy has used the method on its first participant. "The Sanford Project: T-Rex Study" is a collaborative study between Sanford Health and Caladrius Biosciences, Inc., for adolescents with newly onset type 1 diabetes.
Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with arthritis, but there is not enough evidence to support one kind of DMARD over another, according to a new report from HHS' Agency for Healthcare Research and Quality.
› Verified 9 days ago
| Entity Name | Honorhealth Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043851793 PECOS PAC ID: 1557274057 Enrollment ID: O20031119000717 |
News Archive
In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Results from a nationwide study in the USA show that women of menopausal age have a rate of asthma hospitalization that is more than twice that of men of the same age.
A clinical trial studying the body's ability to fight type 1 diabetes using cell therapy has used the method on its first participant. "The Sanford Project: T-Rex Study" is a collaborative study between Sanford Health and Caladrius Biosciences, Inc., for adolescents with newly onset type 1 diabetes.
Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with arthritis, but there is not enough evidence to support one kind of DMARD over another, according to a new report from HHS' Agency for Healthcare Research and Quality.
› Verified 9 days ago
| Entity Name | Honorhealth Ambulatory |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407050917 PECOS PAC ID: 5991603110 Enrollment ID: O20071005000449 |
News Archive
In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Results from a nationwide study in the USA show that women of menopausal age have a rate of asthma hospitalization that is more than twice that of men of the same age.
A clinical trial studying the body's ability to fight type 1 diabetes using cell therapy has used the method on its first participant. "The Sanford Project: T-Rex Study" is a collaborative study between Sanford Health and Caladrius Biosciences, Inc., for adolescents with newly onset type 1 diabetes.
Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with arthritis, but there is not enough evidence to support one kind of DMARD over another, according to a new report from HHS' Agency for Healthcare Research and Quality.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tiffany Courtney Pankow, MD 4400 N 32nd St, Suite 110, Phoenix, AZ 85018-3953 Ph: (602) 956-9595 | Dr Tiffany Courtney Pankow, MD 4400 N 32nd St, Suite 110, Phoenix, AZ 85018-3953 Ph: (602) 956-9595 |
News Archive
In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.
Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Results from a nationwide study in the USA show that women of menopausal age have a rate of asthma hospitalization that is more than twice that of men of the same age.
A clinical trial studying the body's ability to fight type 1 diabetes using cell therapy has used the method on its first participant. "The Sanford Project: T-Rex Study" is a collaborative study between Sanford Health and Caladrius Biosciences, Inc., for adolescents with newly onset type 1 diabetes.
Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with arthritis, but there is not enough evidence to support one kind of DMARD over another, according to a new report from HHS' Agency for Healthcare Research and Quality.
› Verified 9 days ago
Dr. Serena Dawn Woods-grimm, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 201 N Central Ave, Phoenix, AZ 85004 Phone: 602-221-6326 | |
Michael Devin Taylor, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree - Family Medicine #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-4122 | |
Dr. Umar Iqbal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree Building - Window #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-7176 | |
Jessica Ann Wright, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-1000 | |
Meggan E Bauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4250 E Camelback Rd Ste K100, Phoenix, AZ 85018 Phone: 602-224-9218 | |
Dr. James W. Fisher, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12450 N 32nd St Ste 3, Phoenix, AZ 85032 Phone: 602-996-0924 Fax: 602-482-2624 | |
Geoffrey Peter Radoff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 West Greenway, Suite 210, Phoenix, AZ 85023 Phone: 602-993-0200 Fax: 602-993-0207 |